ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Patient-reported distress and correlates while on adjuvant endocrine therapy following breast cancer treatment among post-menopausal women: a group-based trajectory model analysis.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine changes in patient-reported distress in female breast cancer (hormone-receptor-positive, stages 1-3) patients aged 55 + taking adjuvant endocrine therapy (AET).
methodsA retrospective cohort was constructed using the electronic health record (EHR) at a single Midwestern site from 2014 to 2019. Patients (N = 390) were included if they had completed two or more distress thermometer (DT) assessments. The DT is scored from 0 to 10; four is the threshold for clinically concerning distress. Trajectories were assigned using group-based trajectory modeling analyses. Predictors of group membership were identified using a cross-validated lasso algorithm.
resultsThe best-fit model included four groups. Group 1 (22%) had no distress, Group 2 (29%) had low distress (average DT = 0.8) that remained low, Group 3 (33%) had medium-low distress (2.7) that remained low, and Group 4 (16%) had high distress (6.2) that decreased but remained high (5) over time. Higher initial DT value was associated with a decreased odds of membership in Group 1 (OR = 0.88; 95% CI (0.80-0.95)) and increased in Group 4 (OR = 1.14; 95% CI (1.06-1.25)). Endorsement of sleep issues was associated with decreased odds of membership in Group 1 (OR = 0.59; 95% CI (0.40-0.87)) and increased odds of membership in Group 3 (OR = 1.53; 95% CI (1.11-2.26)).
conclusionThe majority of post-menopausal women do not report distress while taking AET; however, one in six reports high distress that did not dissipate with time. This work adds to the understanding of distress in breast cancer survivors and supports the use of the DT in providing actionable information on distress and its causes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.